| Original language | English |
|---|---|
| Pages (from-to) | 3603-3604 |
| Number of pages | 2 |
| Journal | Journal of Allergy and Clinical Immunology: In Practice |
| Volume | 8 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Nov 1 2020 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Omalizumab concentrations in pregnancy and lactation : A case study. / Saito, Jumpei; Yakuwa, Naho; Sandaiji, Noriko et al.
In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, No. 10, 01.11.2020, p. 3603-3604.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Omalizumab concentrations in pregnancy and lactation
T2 - A case study
AU - Saito, Jumpei
AU - Yakuwa, Naho
AU - Sandaiji, Noriko
AU - Uno, Chiaki
AU - Yagishita, Sachiko
AU - Suzuki, Tomo
AU - Ozawa, Katsusuke
AU - Kamura, Shunsuke
AU - Yamatani, Akimasa
AU - Wada, Seiji
AU - Sago, Haruhiko
AU - Murashima, Atsuko
N1 - Funding Information: This work was supported by the Research Program from the Japanese Agency for Medical Research and Development (JP19mk0101086h0003) awarded to A. Murashima and by a domestic research and development grant from National Center for Child Health and Development (2019C-6) awarded to J. Saito.Conflicts of interest: A. Murashima has received research grants from Astellas Pharma. and Chugai Pharmaceutical, and has received lecture fees from Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., and Bristol-Myers K.K. The rest of the authors declare that they have no conflicts of interest. Funding Information: This work was supported by the Research Program from the Japanese Agency for Medical Research and Development ( JP19mk0101086h0003 ) awarded to A. Murashima and by a domestic research and development grant from National Center for Child Health and Development ( 2019C-6 ) awarded to J. Saito. Funding Information: Conflicts of interest: A. Murashima has received research grants from Astellas Pharma . and Chugai Pharmaceutical , and has received lecture fees from Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., and Bristol-Myers K.K. The rest of the authors declare that they have no conflicts of interest.
PY - 2020/11/1
Y1 - 2020/11/1
UR - http://www.scopus.com/inward/record.url?scp=85087302012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087302012&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2020.05.054
DO - 10.1016/j.jaip.2020.05.054
M3 - Article
C2 - 32544544
AN - SCOPUS:85087302012
SN - 2213-2198
VL - 8
SP - 3603
EP - 3604
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 10
ER -